Evaluating Acetaminophen in Joint Arthroplasty

Total joint arthroplasty, encompassing total hip arthroplasty and total knee arthroplasty, represents one of the most common surgical interventions performed globally to restore joint mobility. However, managing acute postoperative pain following these major orthopedic procedures remains a significant clinical challenge. Inadequate pain control after joint replacement can impede early physical rehabilitation, prolong hospital stay duration, increase healthcare expenses, and lower patient satisfaction. Consequently, modern perioperative care relies on multimodal analgesia strategies designed to maximize pain relief while minimizing opioid-related adverse effects such as respiratory depression, sedation, and postoperative nausea. Within these multimodal frameworks, non-opioid medications serve as foundational elements. Among them, acetaminophen is widely prescribed across diverse healthcare settings due to its favorable safety profile. Despite its routine clinical adoption, uncertainty persists regarding optimal administration routes, dosing schedules, and comparative efficacy among different formulations. Evaluating the clinical role of acetaminophen in joint arthroplasty is essential for refining postoperative care protocols and establishing evidence-based surgical standards.

Network Meta-Analysis Methodology and Findings

To address clinical uncertainties surrounding perioperative analgesic choices, researchers conducted a comprehensive systematic review and Bayesian network meta-analysis. This investigation evaluated the comparative efficacy of various acetaminophen and propacetamol regimens in patients undergoing total hip or knee replacement. Systematic searches across primary biomedical databases identified fifteen randomized controlled trials involving nearly two thousand surgical patients across six distinct therapeutic interventions. Outcomes analyzed included standardized mean differences in pain scores evaluated at six, twelve, and twenty-four hours postoperatively, alongside cumulative twenty-four-hour supplemental analgesic consumption. Utilizing Bayesian statistical modeling, investigators calculated surface under cumulative ranking curve percentages to establish relative hierarchical rankings among studied regimens. The findings demonstrated that intravenous administrations of propacetamol and acetaminophen administered in multiple doses achieved the highest rankings for reducing twenty-four-hour supplemental analgesic requirements. Both intravenous interventions showed statistically significant superiority compared to control groups, highlighting their potential value in lowering overall postoperative opioid consumption.

Analgesic Consumption and Pain Score Trends

A detailed examination of statistical findings reveals specific nuance across different post-surgical time intervals and therapeutic endpoints. Regarding overall supplemental analgesic consumption over twenty-four hours, multiple-dose intravenous propacetamol achieved top ranking with a surface under cumulative ranking curve score of ninety percent, closely followed by multiple-dose intravenous acetaminophen at eighty-seven percent. Both regimens demonstrated robust reductions in supplemental pain medication reliance compared to non-active controls. Assessing pain intensity scores at twenty-four hours, multiple oral acetaminophen doses and multiple intravenous acetaminophen doses both successfully reduced pain scores compared with control cohorts, displaying modest yet clinically meaningful benefits. Evaluation of pain scores at twelve hours demonstrated no statistically significant differences among evaluated therapeutic interventions. Conversely, at the early six-hour postoperative milestone, multiple-dose intravenous propacetamol exhibited the strongest analgesic impact, recording the largest standardized mean difference. These temporal variations emphasize that while acetaminophen-based strategies consistently provide valuable opioid-sparing effects, immediate pain reduction capabilities fluctuate across initial recovery periods.

Comparative Efficacy of Intravenous versus Oral Routes

The comparative clinical effectiveness of intravenous versus oral acetaminophen formulations remains a central point of discussion among surgical teams. Proponents of intravenous formulations emphasize rapid onset of action and convenience for patients experiencing perioperative nausea or oral intake restrictions. Conversely, oral acetaminophen presents clear financial advantages, administrative ease, and lower overall treatment costs, making it an attractive option for routine inpatient care. The network meta-analysis indicated that while multiple intravenous doses provided superior ranking for supplemental analgesic reduction, oral administration delivered comparable efficacy in reducing overall pain scores at twenty-four hours. This parity suggests that for surgical candidates who tolerate oral medications, oral acetaminophen offers a cost-effective alternative without compromising overall twenty-four-hour pain control. Clinicians must weigh modest pharmacokinetic advantages of intravenous delivery against substantial cost differentials associated with parenteral formulations. Consequently, drug selection should be tailored individually based on patient status, gastrointestinal tolerance, and institutional resources.

Clinical Implications for Multimodal Protocols

Integrating these research findings into routine surgical practice requires balanced interpretation of statistical rankings and clinical feasibility. Although mathematical metrics like ranking curve percentages help evaluate therapeutic options, clinicians should interpret them alongside absolute effect sizes and practical healthcare constraints. Acetaminophen-based protocols offer modest postoperative analgesic and opioid-sparing benefits after total joint arthroplasty, reinforcing their position as core components of multimodal analgesic pathways. However, the study demonstrated that no single regimen was consistently superior across every evaluated outcome measure and time point. Relying solely on acetaminophen is rarely sufficient for controlling intense post-arthroplasty pain. Instead, optimal pain control requires combining acetaminophen with other non-opioid modalities, such as nonsteroidal anti-inflammatory drugs, local infiltration analgesia, regional nerve blocks, and low-dose systemic opioids when necessary. Perioperative care teams should leverage intravenous protocols during early recovery, transitioning smoothly to oral formulations as recovery progresses.

Future Directions in Postoperative Pain Care

As health systems continuously strive to enhance surgical recovery and implement value-based care models, optimizing perioperative pain management protocols remains essential. Findings from this network meta-analysis highlight the importance of designing evidence-based, flexible analgesic pathways tailored to individual patient needs after major orthopedic surgery. Future prospective clinical trials should focus on exploring head-to-head comparisons of specific timing protocols, investigating potential synergistic interactions with novel local anesthetics, and evaluating long-term functional recovery outcomes beyond twenty-four hours. Additionally, health economic analyses evaluating the cost-effectiveness of intravenous versus oral acetaminophen regimens in real-world clinical settings will assist hospital pharmacy committees in establishing rational drug formularies. Ultimately, combining acetaminophen with multimodal analgesia strategies provides safe, effective, and balanced postoperative recovery for joint replacement patients.

Frequently Asked Questions

How does acetaminophen reduce supplemental opioid reliance following total joint replacement?

Acetaminophen operates primarily by inhibiting central prostaglandin synthesis and modulating descending inhibitory pain pathways within the central nervous system. By establishing a consistent baseline level of analgesia throughout the early perioperative phase, acetaminophen effectively elevates pain thresholds. Consequently, patients experience less severe breakthrough pain, which significantly reduces their overall demand for supplemental opioid analgesics, thereby lowering the risk of opioid-induced adverse events following major surgery.

Is intravenous acetaminophen clinically superior to oral acetaminophen after joint arthroplasty?

Intravenous acetaminophen provides rapid peak plasma concentrations, making it particularly advantageous during immediate early recovery when patients may experience nausea or oral intake restrictions. However, research demonstrates that oral acetaminophen offers comparable pain reduction at twenty-four hours post-surgery. Therefore, while intravenous administration ranks higher for initial supplemental analgesic reduction, oral formulations remain highly effective, convenient, and significantly more cost-effective for suitable candidates.

Should acetaminophen be used as a standalone analgesic after major joint replacement?

No, acetaminophen should not be relied upon as a monotherapy following total joint arthroplasty. Major orthopedic surgeries generate significant nociceptive and inflammatory pain signals that require a comprehensive multimodal analgesia strategy. Acetaminophen works best as a foundational adjunct alongside nonsteroidal anti-inflammatory drugs, regional peripheral nerve blocks, local surgical site infiltration, and judicious use of rescue opioids to achieve optimal pain control.

Disclaimer: This content is for informational and educational purposes only. It is not intended as formal medical advice or a substitute for professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.

References

Liao Y et al. Efficacy of acetaminophen for pain management following total joint arthroplasty: Systematic review and network meta-analysis. J Orthop Sci. 2026 Aug 12. doi: undefined. PMID: 42586917.

American Association of Hip and Knee Surgeons. Guidelines on the use of acetaminophen in primary total joint arthroplasty. J Arthroplasty. 2020;35(10):2715-2729.

Sun L, Zhu X, Zou J, Li Y, Han W. Comparison of intravenous and oral acetaminophen for pain control after total knee and hip arthroplasty: A systematic review and meta-analysis. Medicine (Baltimore). 2018;97(6):e9751.